Chemed Corp (CHE) — SEC Filings
Chemed Corp (CHE) — 30 SEC filings. Latest: 10-Q (Apr 28, 2026). Includes 15 8-K, 7 10-Q, 2 DEF 14A.
Overview
Chemed Corp (CHE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Apr 28, 2026: Chemed Corporation filed its quarterly report (10-Q) on April 28, 2026, for the period ending March 31, 2026. The filing includes various exhibits such as the 10-Q itself, certifications, and XBRL data. Chemed Corporation is headquartered in Cincinnati, Ohio, and operates in the Home Health Care Ser
Sentiment Summary
Across 30 filings, the sentiment breakdown is: 1 bullish, 28 neutral, 1 mixed. The dominant filing sentiment for Chemed Corp is neutral.
Filing Type Overview
Chemed Corp (CHE) has filed 7 10-Q, 15 8-K, 1 DEFR14A, 2 DEF 14A, 1 10-K/A, 2 10-K, 2 SC 13G/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (30)
Risk Profile
Risk Assessment: Of CHE's 23 recent filings, 0 were flagged as high-risk, 3 as medium-risk, and 20 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $1.89B |
| Net Income | $188.5M |
| EPS | $4.46 |
| Cash Position | $129.8M |
| Total Assets | $1.62B |
Key Executives
- Tony G. Alvarez II
- David L. Watson
Industry Context
CHEMED CORP operates in sectors that require significant service delivery and potentially involve physical goods. The competitive landscape likely involves companies with similar operational models, where efficiency in service provision and cost management are critical. Industry trends may include increasing demand for specialized services, evolving regulatory environments, and pressure on input costs.
Top Tags
financial-reporting (6) · 8-k (6) · 10-Q (5) · corporate-governance (5) · healthcare (4) · financials (3) · financial-results (3) · Chemed Corp (3) · quarterly-report (2) · Healthcare Services (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Income | $188.5M | Decreased by 11.0% for the nine months ended September 30, 2025, compared to $211.7M in 2024. |
| Service Revenues and Sales | $1.89B | Increased by 5.6% for the nine months ended September 30, 2025, from $1.79B in 2024. |
| Cost of Services Provided and Goods Sold | $1.29B | Increased by 10.4% for the nine months ended September 30, 2025, from $1.17B in 2024. |
| Purchases of Treasury Stock | $256.9M | Increased significantly from $152.0M in the prior nine-month period, indicating aggressive share buybacks. |
| Cash and Cash Equivalents | $129.8M | Decreased by $48.6M from $178.4M at December 31, 2024, to September 30, 2025. |
| Earnings Per Share (EPS) | $4.46 | Decreased from $5.04 in Q3 2024 to $4.46 in Q3 2025. |
| Effective Income Tax Rate | 23.1% | Decreased in Q3 2025 from 25.0% in Q3 2024. |
| Cash Dividends Per Share | $0.60 | Increased from $0.50 in Q3 2024 to $0.60 in Q3 2025. |
| Revenue | $1.25B | Increased by 8.5% from $1.15B in H1 2024 to $1.25B in H1 2025 |
| Revenue Growth | 8.5% | Percentage increase in revenue for the six months ended June 30, 2025 |
| Net Income Growth | 15.2% | Percentage increase in net income for the six months ended June 30, 2025 |
| Shares Repurchased | 1.5M | Number of common shares repurchased during the six months ended June 30, 2025 |
| Share Buyback Value | $750M | Total value of common shares repurchased during the six months ended June 30, 2025 |
| Reporting Period | Q1 2025 | First quarter of 2025 financial data |
| Fiscal Year End | 1231 | Indicates the end of the company's fiscal year |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Chemed Corp (CHE)?
Chemed Corp has 30 recent SEC filings from Jan 2024 to Apr 2026, including 15 8-K, 7 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of CHE filings?
Across 30 filings, the sentiment breakdown is: 1 bullish, 28 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Chemed Corp SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Chemed Corp (CHE) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Chemed Corp?
Key financial highlights from Chemed Corp's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for CHE?
The investment thesis for CHE includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Chemed Corp?
Key executives identified across Chemed Corp's filings include Tony G. Alvarez II, David L. Watson.
What are the main risk factors for Chemed Corp stock?
Of CHE's 23 assessed filings, 0 were flagged high-risk, 3 medium-risk, and 20 low-risk.
What are recent predictions and forward guidance from Chemed Corp?
Forward guidance and predictions for Chemed Corp are extracted from SEC filings as they are enriched.